Bixiye
QP3-18 Pharmacy Benefit Update - Helixate FS Will No Longer Be Covered
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2018
Natiijooyinka Raadinta
Soo bandhiga 2941 - 2950 ee natiijooyinka 3688
Bixiye
QP10-16 Operating System Remit Difference Subscriber Payments
Taariikhda uu dhaqangalayo Barnaamijka: May 04, 2016
Bixiye
QP17-17 Pharmacy Benefit Update - AirDuo Respiclick
Taariikhda dhaqangalka Barnaamijka: Jul 25, 2017
Bixiye
QP13-16 Provider Cost Data Update
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2016
Bixiye
QP60-18 Update: Change to Call Center for Transportation for MHCP Members
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2018
Bixiye
QP99-18 New FEP Employee Opioid Prescription Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Nov 28, 2018
Bixiye
QP66-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Noctiva (desmopressin acetate)
Taariikhda barnaamijka Dhaqangalayso Agosto 21, 2018
Bixiye
QP16-17 Contract Renewal Overlapping with Termination Notices for Interpreter Agencies
Taariikhda dhaqangalka Barnaamijka: Jul 20, 2017
Bixiye
QP20-17 Searching Eligibility and Benefits
Taariikhda barnaamijka Dhaqangalayso Agosto 08, 2017
Bixiye
QP67-18 Pharmacy Benefit Exclusion for Alferon N (interferon alpha-n3), Cytovene (ganciclovir), Foscarvir (foscarnet), Prevymis (letermovir), Trogarzo (ibalizu,ab-uiyk), Vistide (cidofovir) and Zovirax (actclovir)
Taariikhda barnaamijka Dhaqangalayso Agosto 21, 2018